Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference17 articles.
1. World Health Organization. International agency for research on cancer. Globocan World 2018: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. Accessed December 9, 2020
2. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review;Dawood;J Clin Oncol,2010
3. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†;Cardoso;Ann Oncol,2014
4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
5. HER-2/neu oncogene protein and prognosis in breast cancer;Tandon;J Clin Oncol,1989
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Novel Size Exclusion Chromatography Method for the Analysis of Monoclonal Antibodies and Antibody–drug Conjugates by Using Sodium Iodide in the Mobile Phase;Pharmaceutical Research;2024-09-04
2. Long-Term Success With a TDM-1 Biosimilar in Recurrent HER2-Positive Breast Cancer With Multisite Metastases: A Comprehensive Case Study;Cureus;2024-08-16
3. Monoclonal antibody biosimilars for cancer treatment;iScience;2024-06
4. Trastuzumab‐based nanomedicines for breast cancer therapy: Recent advances and future opportunities;Nano Select;2024-02-17
5. The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic review;Critical Reviews in Oncology/Hematology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3